Overview
Yoshiro Fushimi practices in Okayama, Japan. Mr. Fushimi is rated as an Experienced expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Isolated ACTH Deficiency, Type 2 Diabetes (T2D), Diabetic Ketoacidosis, Cushing's syndrome, and Parathyroidectomy.
His clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hyperaldosteronism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Isolated ACTH DeficiencyMr. Fushimi isDistinguished. Learn about Isolated ACTH Deficiency.
- Advanced
- Cushing's syndromeMr. Fushimi isAdvanced. Learn about Cushing's syndrome.
- Diabetic KetoacidosisMr. Fushimi isAdvanced. Learn about Diabetic Ketoacidosis.
- Type 2 Diabetes (T2D)Mr. Fushimi isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Adrenal CancerMr. Fushimi isExperienced. Learn about Adrenal Cancer.
- AtherosclerosisMr. Fushimi isExperienced. Learn about Atherosclerosis.
- Benign Chronic PemphigusMr. Fushimi isExperienced. Learn about Benign Chronic Pemphigus.
- Diabetic Hyperglycemic Hyperosmolar Syndrome
- Diabetic NeuropathyMr. Fushimi isExperienced. Learn about Diabetic Neuropathy.
- Familial HypertriglyceridemiaMr. Fushimi isExperienced. Learn about Familial Hypertriglyceridemia.